CNTX

CONTEXT THERAPEUTICS INC

CNTX·21077P108·US·Common Stock·Healthcare - Biotechnology-13D/G

CNTX (CONTEXT THERAPEUTICS INC) is held by 53 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($3.4M), FRANKLIN TEMPLETON INC ($2.1M), VANGUARD CAPITAL MANAGEMENT LLC ($1.9M). Net institutional sentiment: Bullish.

53
Holders
(1 Elite)
$12.9M
Total Value
72% (57)
Consensus
41 buying - 16 selling
13F: Insider & Congress: Updated regularly
CNTX

Smart Money Verdict

View all
Loading verdict
Held by 53 funds
1 elite

Who's Trading

Source dates: Price Oct 13, 2026 · Insiders none · Activists Aug 14, 2026 · Congress none

ActivistMBMPM BioImpact LLC1.4%Aug 14, 2026
ActivistBOBlue Owl Capital Holdings LP3.2%Aug 12, 2026
ActivistOAOctagon Capital Advisors LP3.3%Jul 31, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
6.2M(+628.6%)$3.4M0.0%-55.89%
43
Unchanged
3.8M$2.1M0.0%-80.78%
0
Increased
3.4M$1.9M0.0%-88.44%
18
Increased
1.8M(+203.2%)$1M0.0%-72.26%
40
Increased
1.4M(+505.3%)$782,8980.0%—
27
Increased
1M(+469.1%)$576,8310.0%-58.18%
39
Increased
645,209(+47.7%)$357,3820.0%-84.64%
22
New
638,878$353,9380.0%-50.36%
36
Increased
615,576(+496.2%)$340,9670.0%-64.74%
26
Increased
433,888(+27.1%)$240,3740.0%-86.18%
29
Decreased
384,528(-87.0%)$211,4900.0%-80.72%
0
New
294,301$163,0130.0%-50.36%
31
Increased
257,068(+2155.4%)$142,3900.0%-56.69%
36
New
227,850$126,2060.0%-50.36%
34
Increased
214,875(+94.9%)$119,0190.0%-64.16%
35
Decreased
147,287(-89.7%)$81,5820.0%-78.85%
0
New
135,300$74,9430.0%-50.36%
29
New
125,852$69,7090.0%-50.36%
29
Decreased
125,852(-0.2%)$69,7090.0%-87.50%
0
New
125,518$69,5240.0%-50.36%
32

Showing 1-20 of 61

1 / 4
CNTXCNTXCONTEXT THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used